Literature DB >> 25174057

The effects of dexmedetomidine on pulmonary artery pressure in experiment.

Y Unal, H K Pampal, M Arslan, C B Demirel, M Alkan.   

Abstract

AIM: The primary purpose of this study is to assess the effects of dexmedetomidine (DEX) infusion on pulmonary artery pressures (PAP), heart rate (HR), and mean arterial pressure (MAP) in pigs. The secondary purpose is to evaluate whether DEX infusion via the pulmonary artery has any beneficial effect over the peripheral IV route.
MATERIALS AND METHODS: Sixteen healthy male pigs (25-35 kg) scheduled for laparoscopy training were used in this study. The animals were randomly allocated into two groups: Group I (n = 9): A loading dose of 1 μg/kg DEX was administered over 10 minutes followed by an infusion of 0.5 μg/kg/hr for one hour via the pulmonary artery catheter. Group II (n = 7): A loading dose of 1 μg/kg DEX was administered over 10 minutes followed by an infusion of 0.5 μg/kg/hr for one hour via the peripheral venous catheter. Mean PAP, HR, MAP, SpO2, and ETCO2 were recorded at 5, 10, 15, 30, 45, and 60 minutes after the initiation of the DEX infusion.
RESULTS: Heart rate and MAP were similar in both groups at all time points. Also, neither the HR nor the MAP deviated from the basal values in Groups I and II at any time point. The mean PAP values were similar in Groups I and II, and in Group I, the mean PAP values were similar to Group I's basal value at all time points. However, in Group II, the mean PAP values at 5, 45, and 60 minutes were significantly lower than Group II's basal value (p = 0.023, p = 0.041, p = 0.015, respectively).
CONCLUSION: DEX infusion did not elevate the mean PAP and the results from the administration of DEX through the peripheral vein and pulmonary artery were similar (Tab. 3, Ref. 13).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25174057     DOI: 10.4149/bll_2014_056

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  5 in total

1.  One-lung ventilation patients: Clinical context of administration of different doses of dexmedetomidine.

Authors:  Hui Jiang; Yu Kang; Chunlin Ge; Zhenying Zhang; Yan Xie
Journal:  J Med Biochem       Date:  2022-04-08       Impact factor: 2.157

2.  Cardiopulmonary Effects of a Partial Intravenous Anesthesia Technique for Laboratory Swine.

Authors:  Justin D Duval; Jessica M Pang; Søren R Boysen; Nigel A Caulkett
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-06-22       Impact factor: 1.232

3.  Dexmedetomidine targets miR-146a and participates in the progress of chronic obstructive pulmonary disease in vivo and in vitro.

Authors:  Na Li; Shuangfeng Li; Yehua Wu; Lu Xiong; Tiejun Li; Dandan Xing; Qiuchang Li; Duozhi Wu
Journal:  Genes Genomics       Date:  2021-01-22       Impact factor: 1.839

4.  Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery: A randomised double-blinded trial.

Authors:  Su Hyun Lee; Namo Kim; Chang Yeong Lee; Min Gi Ban; Young Jun Oh
Journal:  Eur J Anaesthesiol       Date:  2016-04       Impact factor: 4.330

5.  Evaluation of the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease.

Authors:  Ahmed Hasanin; Kareem Taha; Bassant Abdelhamid; Ayman Abougabal; Mohamed Elsayad; Amira Refaie; Sarah Amin; Shaimaa Wahba; Heba Omar; Mohamed Maher Kamel; Yaser Abdelwahab; Shereen M Amin
Journal:  BMC Anesthesiol       Date:  2018-08-14       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.